p53 Immunohistochemical expression in Barrett's esophagus before and after endoscopic ablation by argon plasma coagulation

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 3, 2005, Pages 259-263

  Lopes, César Vivian ^a,c   Pereira Lima, Júlio ^a,b   Hartmann, Antônio Atalíbio ^a  

^a Santa Casa Complexo Hospitalar   (Brazil)

^b FUGAST   (Brazil)

^c NONE   (Brazil)

Author keywords

Argon plasma coagulation; Barrett's esophagus; Immunohistochemistry; p53

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL;

ANTIBODIES, MONOCLONAL; BARRETT ESOPHAGUS; BIOLOGICAL MARKERS; BIOPSY; DISEASE PROGRESSION; ESOPHAGOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LASER COAGULATION; MALE; METAPLASIA; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16444368261     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510011533     Document Type: Article

References (32)

1. DeMeester SR, DeMeester TR. Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303-21.
2. Geboes K, Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000;37:99-107.
3. Sampliner RE, and The Practice Parameters Committee of The American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
4. Jankowski JA, Wright NA, Meltzer SJ, Triadafilopoulos G, Geboes K, Casson AG, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
5. Cameron AJ. Management of Barrett's esophagus. Mayo Clin Proc 1998;73:457-61.
6. Morales TG, Sampliner RE. Barrett's esophagus: update on screening, surveillance, and treatment. Arch Intern Med 1999;159:1411-6.
7. Triadafilopoulos G. Proton pump inhibitors for Barrett's oesophagus. Gut 2000;46:144-6.
8. Haag S, Nandurkar S, Talley NJ. Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc 1999;50:229-40.
9. Ortiz A, Martinez de Haro LF, Parrilla P, Morales G, Molina J, Bermejo J, et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 1996;83:274-8.
10. Pereira-Iima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, et al. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 2000;95:1661-8.
11. Koop H. Reflux Disease and Barrett's esophagus. Endoscopy 2000;32:101-7.
12. Bremner CG, DeMeester TR. Proceedings from an international conference on ablation therapy for Barrett's mucosa. Dis Esophagus 1998;11:1-27.
13. Wijnhoven BPL, Tilanus HW, Dinjens WNM. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001;233:322-37.
14. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin Proc 2001;76:438-46.
15. Kubba AK, Poole NA, Watson A. Role of p53 assessment in management of Barrett's esophagus. Dig Dis Sci 1999;44:659-67.
16. Bian Y-S, Osterheld M-C, Bosman FT, Benhattar J, Fontolliet C. p53 Gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol 2001;14:397-403.
17. Hardwick RH, Shepherd NA, Moorghen M, Newcomb PV, Alderson D. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut 1994;35:764-8.
18. Krishnadath KK, Tilanus HW, Blankenstein MV, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995;175:175-80.
19. Ireland AP, Clark GWB, DeMeester TR. Barrett's esophagus: the significance of p53 in clinical practice. Ann Surg 1997;225:17-30.
20. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993;104:1686-91.
21. Wang T, Liu B, Wang L, Wang M, Jiang J. The expression and implication of proliferating cell nuclear antigen and p53 in reflux esophagitis lesions. Zhonghua Nei Ke Za Zhi 2002;41:39-42.
22. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol 2001;25:1204-7.
23. Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ. Loss of tumour marker-immunostaining intensity on stored paraffin slides of breast cancer. J Natl Cancer Inst 1996;7:1054-9.
24. Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem 1997;45:327-43.
25. Cross SS. Grading and scoring in histopathology. Histopathology 1998;33:99-106.
26. Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
27. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J Pathol 1994;172:1-4.
28. Hofseth LJ, Salto S, Hussain SP, Espey MG, Miranda KM, Araki Y, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. PNAS 2003;100:143-8.
29. Fitzpatrick FA. Inflammation, carcinogenesis and cancer. Int Immunopharmacol 2001;1:1651-67.
30. Oren M. Regulation of the p53 tumour suppressor protein. J Biol Chem 1999;274:36031-4.
31. Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998;22:239-45.
32. Garewal HS, Ramsey L, Sharma P, Kraus K, Sampliner R, Fass R. Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 1999;94:2829-33.